| Perspectives in platelet-activating factor research. P Braquet, L Touqui, TY Shen, BB Vargaftig Pharmacological Reviews 39 (2), 97-145, 1987 | 1878 | 1987 |
| The role of platelet-activating factor in platelet aggregation M Chignard, JP Le Couedic, M Tence, BB Vargaftig, J Benveniste Nature 279 (5716), 799-800, 1979 | 531 | 1979 |
| Platelet-activating factor induces a platelet-dependent bronchoconstriction unrelated to the formation of prostaglandin derivatives BB Vargaftig, J Lefort, M Chignard, J Benveniste European journal of pharmacology 65 (2-3), 185-192, 1980 | 523 | 1980 |
| Background and present status of research on platelet‐activating factor (PAF‐acether) BB Vargaftig, M Chignard, J Benveniste, J Lefort, F Wal Annals of the New York Academy of Sciences 370 (1), 119-137, 1981 | 392 | 1981 |
| Cutting edge: invariant Vα14 NKT cells are required for allergen-induced airway inflammation and hyperreactivity in an experimental asthma model M Lisbonne, S Diem, A de Castro Keller, J Lefort, LM Araujo, P Hachem, ... The Journal of Immunology 171 (4), 1637-1641, 2003 | 368 | 2003 |
| Present concepts on the mechanisms of platelet aggregation BB Vargaftig, M Chignard, J Benveniste Biochemical pharmacology 30 (4), 263-271, 1981 | 333 | 1981 |
| Interleukin-10 inhibits antigen-induced cellular recruitment into the airways of sensitized mice. C Zuany-Amorim, S Haile, D Leduc, C Dumarey, M Huerre, BB Vargaftig, ... The Journal of clinical investigation 95 (6), 2644-2651, 1995 | 328 | 1995 |
| Requirement for γδ T cells in allergic airway inflammation C Zuany-Amorim, C Ruffie, S Haile, BB Vargaftig, P Pereira, M Pretolani Science 280 (5367), 1265-1267, 1998 | 327 | 1998 |
| Murine models of asthma JC Kips, GP Anderson, JJ Fredberg, U Herz, MD Inman, M Jordana, ... European Respiratory Journal 22 (2), 374-382, 2003 | 287 | 2003 |
| Platelet activation—a role for a 40K anti-phospholipase A2 protein indistinguishable from lipocortin L Touqui, B Rothhut, AM Shaw, A Fradin, BB Vargaftig, F Russo-Marie Nature 321 (6066), 177-180, 1986 | 286 | 1986 |
| Selective inhibition by mepacrine of the release of “rabbit aorta contracting substance” evoked by the administration of bradykinin BB Vargaftig, ND Hai Journal of Pharmacy and Pharmacology 24 (2), 159-161, 1972 | 281 | 1972 |
| Platelet‐activating factor (PAF‐acether) secretion from platelets: effect of aggregating agents M Chignard, JPL Couedic, BB Vargaftig, J Benvenisie British journal of haematology 46 (3), 455-464, 1980 | 265 | 1980 |
| Platelet Aggregation induced by Arachidonic Acid is accompanied by Release of Potential Inflammatory Mediators distinct from PGE2 and PGF2 BB Vargaftig, P Zirinis Nature New Biology 244, 114-116, 1973 | 244 | 1973 |
| Eosinophil recruitment into guinea pig lungs after PAF-acether and allergen administration: modulation by prostacyclin, platelet depletion, and selective antagonists A Lellouch-Tubiana, J Lefort, MT Simon, A Pfister, BB Vargaftig American Review of Respiratory Disease, 2012 | 242 | 2012 |
| Evidence for platelet-activating factor as a mediator of endotoxin-induced gastrointestinal damage in the rat: effects of three platelet-activating factor antagonists JL Wallace, G Steel, BJR Whittle, V Lagente, B Vargaftig Gastroenterology 93 (4), 765-773, 1987 | 217 | 1987 |
| Bacterial lipopolysaccharide signaling through Toll-like receptor 4 suppresses asthma-like responses via nitric oxide synthase 2 activity D Rodríguez, AC Keller, EL Faquim-Mauro, MS de Macedo, FQ Cunha, ... The Journal of Immunology 171 (2), 1001-1008, 2003 | 214 | 2003 |
| Antibody to very late activation antigen 4 prevents antigen-induced bronchial hyperreactivity and cellular infiltration in the guinea pig airways. M Pretolani, C Ruffie, JR Lapa e Silva, D Joseph, RR Lobb, BB Vargaftig The Journal of experimental medicine 180 (3), 795-805, 1994 | 209 | 1994 |
| A MARCKS-related peptide blocks mucus hypersecretion in a mouse model of asthma M Singer, LD Martin, BB Vargaftig, J Park, AD Gruber, Y Li, KB Adler Nature medicine 10 (2), 193-196, 2004 | 203 | 2004 |
| Eosinophil recruitment into the respiratory epithelium following antigenic challenge in hyper-IgE mice is accompanied by interleukin 5-dependent bronchial hyperresponsiveness. SY Eum, S Haile, J Lefort, M Huerre, BB Vargaftig Proceedings of the National Academy of Sciences 92 (26), 12290-12294, 1995 | 199 | 1995 |
| Generation of lyso-phospholipids from surfactant in acute lung injury is mediated by type-II phospholipase A2 and inhibited by a direct surfactant protein A-phospholipase A2 … L Arbibe, K Koumanov, D Vial, C Rougeot, G Faure, N Havet, S Longacre, ... The Journal of clinical investigation 102 (6), 1152-1160, 1998 | 195 | 1998 |
